Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|April 8, 2022
Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37Maria Teresa Borrello, Derek Mann
Expert Review of Molecular Diagnostics|July 13, 2021
Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infectionNoam Shohat, Steven Yacovelli, Emanuele Chisari, et al.
Operative Techniques in Otolaryngology--Head and Neck Surgery|May 3, 2022
COVID-19 and laryngological surgeryParastou Azadeh Ranjbar, Ahmad Issa Al Omari, Derek Mann, et al.
Journal of Cellular and Molecular Medicine|December 14, 2011
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLLShilu Amin, Meagan Walsh, Caroline Wilson, et al.
Comparative Hepatology|February 13, 2004
N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1Frank Murphy, Julian Waung, Jane Collins, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2024
Safety of Ambulatory Surgery For Obstructive Sleep Apnea: A Retrospective ReviewDylan Gregory Bertoni, Emily Garvey, Neha Garg, et al.
The Journal of Biological Chemistry|November 6, 2003
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammationGiovanni Monteleone, Jelena Mann, Ivan Monteleone, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 8, 2009
Active matrix metalloproteinase-2 promotes apoptosis of hepatic stellate cells via the cleavage of cellular N-cadherinStephen N Hartland, Frank Murphy, Rebecca L Aucott, et al.
JCO Oncology Practice|July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic AdenocarcinomaKelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.
Plos One|April 19, 2017
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitisStuart McPherson, Nina Wilkinson, Dina Tiniakos, et al.
Pageof 2